Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an …

Purpose of Review The introduction of the National Free Antiretroviral Therapy Program (NFATP)
in 2003 by the China National Center for AIDS/STD Control and Prevention has led to …

Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated
with disability and premature death. Up-to-date estimates of the burden of rheumatoid …

Before widespread vaccination programmes, potential side-effects and flares after COVID-19
vaccination were frequent reasons for vaccine hesitancy among people with rheumatic …

Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs). …

Background HIV-related stigma among people living with HIV/AIDS (PLWHA) has been
associated with many negative consequences, including poor adherence to therapy and undue …

People ageing with HIV face crucial challenges that can compromise their long-term health,
one of which is stigma. HIV-related stigma can interact with other coexistent inequities to …

Objective To assess the incidence, presentation, and management of rheumatoid arthritis (RA)
in patients with HIV, including the use of disease‐modifying antirheumatic drugs (…

Although the public health emergency associated with the COVID‐19 pandemic has ended,
challenges remain, especially for individuals with rheumatic diseases. We aimed to assess …